OPTIMAL DURATION OF DUAL ANTIPLATELET THERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION: A NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Coronary artery disease is commonly managed with percutaneous coronary intervention (PCI) followed by dual antiplatelet therapy (DAPT). However, bleeding risk has driven interest in shorter DAPT durations. This network meta-analysis evaluates the efficacy and safety of different DAPT durations after PCI. P...